Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

188
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
188
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

32
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
32

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Life Stressors in Young Americans are Linked via Asymmetric U-Shapes to Mental Health Severity.

Research square·2026
Same author

A century of suicide: Insights from long-term data in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The doctor is not in, but the Chatbot is: Utah's experience regulating mental health AI.

NPJ digital medicine·2026
Same author

Predicting the onset of internalizing disorders in early adolescence using deep learning optimized with AI.

Frontiers in psychiatry·2025
Same author

RiskPath: Explainable deep learning for multistep biomedical prediction in longitudinal data.

Patterns (New York, N.Y.)·2025
Same author

Selectively predicting the onset of ADHD, oppositional defiant disorder, and conduct disorder in early adolescence with high accuracy.

Frontiers in psychiatry·2023

Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

979

RiskPath: Explainable deep learning for multistep biomedical prediction in longitudinal data.

Nina de Lacy1, Michael Ramshaw1, Wai Yin Lam2

  • 1Department of Psychiatry, University of Utah, Salt Lake City, Utah.

Medrxiv : the Preprint Server for Health Sciences
|October 7, 2024
PubMed
Summary

RiskPath is a new explainable AI toolbox for disease risk stratification. It uses advanced timeseries AI methods to predict disease outcomes and understand risk factors over time.

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

653
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Related Experiment Videos

Last Updated: Jun 11, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

979
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

653
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Area of Science:

  • Artificial Intelligence
  • Biomedical Informatics
  • Computational Biology

Background:

  • Multifactorial diseases arise from complex interactions of risks over time.
  • Timeseries AI shows promise for predicting disease outcomes using longitudinal data.
  • Current risk stratification tools face limitations in complexity, size, and explainability.

Purpose of the Study:

  • To introduce RiskPath, an explainable AI toolbox for advanced timeseries analysis in disease risk stratification.
  • To provide tools for optimizing model topology and exploring performance-complexity tradeoffs.
  • To enable mapping of predictor importance, visualization of risk-contributing time epochs, and development of compact clinical models.

Main Methods:

  • Development of an explainable AI toolbox named RiskPath.
  • Integration of theoretically-informed optimization for model prediction.
  • Inclusion of modules for analyzing predictor importance, time epochs, and model compression.

Main Results:

  • RiskPath offers advanced timeseries methods tailored for risk stratification.
  • The toolbox facilitates understanding of predictor dynamics and disease progression.
  • It enables the creation of simplified, high-performance models for clinical use.

Conclusions:

  • RiskPath addresses limitations in current AI-driven risk stratification tools.
  • The toolbox enhances explainability and clinical applicability of predictive models.
  • It supports robust risk assessment and personalized medicine through longitudinal data analysis.